Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (9)

2024

  1. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2021

  1. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428

  2. Post-covid syndrome: A reflection and opinion paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279

2013

  1. Expansion of serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain

    Clinical and Vaccine Immunology, Vol. 20, Núm. 10, pp. 1524-1530

  2. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011

    Pediatric Infectious Disease Journal

2011

  1. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 6, pp. 471-474

  2. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar

    Clinical and Vaccine Immunology, Vol. 18, Núm. 1, pp. 89-94